Together We Can Eliminate Rabies

Together We Can Eliminate Rabies: Vaccinate your dog with Nobivac 3-year Rabies vaccine at Animal Medical Center of Chicago and we will donate a rabies vaccine to a pet in need.

Rabies is a deadly viral disease that can affect dogs and cats, wild animals, and humans. It is transmitted by the bite or scratch of an infected animal. In under-developed countries, the most common source of rabies in humans is exposure to unvaccinated dogs.

Worldwide, more than 59,000 people die from rabies each year. Children are at greatest risk of acquiring rabies, since they are more likely to be bitten or scratched by rabid dogs. Countries with the highest fatalities from rabies are India, Democratic Republic of the Congo, Ethiopia, China and Myanmar. Treatment is often unaffordable or unavailable in these under-developed countries.

Fortunately, prevention of this deadly disease through vaccination of dogs has been shown to be an effective way to halt the spread of rabies and save lives! Twelve years ago, the Global Alliance for Rabies Control, together with numerous health organizations around the world, set the goal of eliminating the transmission of rabies by infected dogs to humans by 2030. Animal Medical Center of Chicago is committed to this cause and is proud to help support programs that supply rabies vaccinations to areas at greatest risk for disease.

Starting January 2018, in alliance with our steadfast commitment to helping others, we have partnered with Merck Animal Health to help fight against rabies. For every Nobivac 3-year Rabies vaccine that we administer to our patients, we will donate one rabies vaccine to Mission Rabies and Afya Serengeti. By vaccinating your dog at Animal Medical Center of Chicago, TOGETHER we can eliminate rabies from the world!

In the next few months, we are hoping to persuade the makers of our 1-year non-adjuvanted rabies vaccine for cats to join us in this philanthropic project. So stay tuned, cat owners, you too, will help us eliminate rabies worldwide!

To learn more about this program, please visit

Share This Story, Choose Your Platform!